Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
163.8 USD | +1.85% | +2.61% | +5.69% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.69% | 285B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B | |
+8.08% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie : Three Democrats Urge FTC To Investigate AbbVie's Humira Pricing Strategy